Advertisement

Lower Airway Complications of Sulfur Mustard Exposure

  • Mostafa GhaneiEmail author
  • Amin Saburi
Chapter

Abstract

The pulmonary complications of sulfur mustard (SM) exposure is the most mortal and morbid complication in exposed cases. In acute phase after exposure, all symptoms can because of airways and alveolar injuries and cell necrosis. Thus, treatment in this phase should be supportive and sometimes critical cares may be mandatory. In the chronic phase, productive cough, thick sputum and dyspnea are more frequent symptoms. Although chronic pulmonary sequels are common in exposed patients, the mechanism of these complications was not clearly described. Although corticosteroids extensively prescribed for treatment in chronic phase, its efficacy is short-term and its complications are serious. Imbalance in apoptosis and repair is seems to justify these symptoms. Therefore, treatments include antioxidant, bronchodilators, and mucolytics in this phase. Lung carcinogenicity of a single exposure to SM was not confirmed. Future studies may be helpful for assessing the genome mutation to resolve prolong symptoms.

Keywords

Sulfur mustard Lung Bronchiolitis obliterans Antioxidant 

Notes

Acknowledgment

We would like to thanks chief and personnel’s of chemical injuries research center, Baqiyatallah University of medical sciences, Tehran, Iran. Also, we thank “Informa Healthcare” for their permission to use their journal content in this chapter. Moreover, we acknowledge Dr. Amini-Harandi and Dr. Amin Abbasi in addition to “Resaneh Takhassosi” publication for permission to use their book contents for this manuscript.

Glossary

Alveoli

Cystic structures at the end of respiratory tree that have a thin layer of cell which charged with the task of gas exchange.

Antioxidant

A molecule which can prevent oxidation and cell injuries.

Apoptosis

Is a gradual process of cell death due to programmed inter and intra cellular signaling.

ARDS

Or acute respiratory distress syndrome which is a complex syndrome due to severe injury to the terminal components of airways and alveoli and pulmonary edema and respiratory failure are its two important sequels.

Bronchiolitis obliterans

The inflammatory involvement of terminal respiratory airways.

Bronchitis

The inflammation in the bronchi that can present with dyspnea and productive cough.

Chemical Warfare agents

Every chemical material which use for military and terroristic propose.

Chest tightness

A sense of heavy on the chest during the respiration

COPD

Or Chronic Obstructive Pulmonary Diseases which includes two main territories; emphysema and chronic bronchitis.

Corticosteroids

Synthetic hormone-like medications using for inflammatory suppression.

Dyspnea

Sensing the breathing that leads to increase the respiration attempts.

Fibrosis

A process in a damaged tissue that is characterized by gathering fibroblasts and collagen deposition.

Hemoptysis

Coughing up the blood that can because of a lesion in upper or lower respiratory tract.

Inflammation

Is a biological interaction between immune cells, threatened cells and pathogens that can present as an interaction complex containing warmness, pain, and swelling.

Interleukin

A class of cytokine family that usually in related to the immune systems cells.

Mutation

A change in normal sequence of genome.

N-Acetyl cysteine

Is a medication with mucolytics, antioxidative and immunomolulating properties.

Necrosis

Is a form of cell injury that leads to the premature and unprogrammed cells death.

Respiratory Airways

Include Upper respiratory tract and Lower respiratory tract which are responsible for providing a pathway to reach oxygen to the alveoli.

Sputum

Liquid secret from mucus cells of airways

Sulfur Mustard

An Alkylating chemical component which is used as a blistering chemical warfare agent that affect lung, eye and skin more than other organs.

References

  1. Aghanouri R, Ghanei M, Aslani J, Keivani-Amine H, Rastegar F, Karkhane A (2004) Fibrogenic cytokine levels in bronchoalveolar lavage aspirates 15 years after exposure to sulfur mustard. Am J Physiol Lung Cell Mol Physiol 287:30CrossRefGoogle Scholar
  2. Akhlaghpoor S, Ahari AA, Shabestari AA, Ghanei M, Ali HA, Shakiba M (2011) Comparison of virtual bronchoscopy with fiberoptic bronchoscopy findings in patients exposed to sulfur mustard gas. Acta Radiol 52:1095–1100PubMedCrossRefGoogle Scholar
  3. Amini M, Oghabian Z (2013) Late-onset radiologic findings of respiratory system following sulfur mustard exposure. Asia Pac J Med Toxicol 2:58–62Google Scholar
  4. Anderson DR, Yourick JJ, Moeller RB, Petrali JP, Young GD, Byers SL (1996) Pathologic changes in rat lungs following acute sulfur mustard inhalation. Inhal Toxicol 8:285–297CrossRefGoogle Scholar
  5. Anderson DR, Taylor SL, Fetterer DP, Holmes WW (2009) Evaluation of protease inhibitors and an antioxidant for treatment of sulfur mustard-induced toxic lung injury. Toxicology 263:41–46PubMedCrossRefGoogle Scholar
  6. Ansarin K, Rezvanyeh S (1987) Changes in flow volume curve up to two years after exposure to sulfur mustard. In: International gas war in Iran, MashhadGoogle Scholar
  7. Attaran D, Towhidi M, Asnaashari AH (2006) Sulfur mustard induced bronchiectasis 15–20 years after exposure, review of 34 cases. Iran J Otorhinolaryngol 18:21–25Google Scholar
  8. Attaran D, Lari SM, Khajehdaluee M, Ayatollahi H, Towhidi M, Asnaashari A, Marallu HG, Mazloomi M, Mood MB (2009) Highly sensitive C-reactive protein levels in Iranian patients with pulmonary complication of sulfur mustard poisoning and its correlation with severity of airway diseases. Hum Exp Toxicol 28:739–745PubMedCrossRefGoogle Scholar
  9. Bagheri MH, Hosseini SK, Mostafavi SH, Alavi SA (2003) High-resolution CT in chronic pulmonary changes after mustard gas exposure. Acta Radiol 44:241–245PubMedCrossRefGoogle Scholar
  10. Bakhtavar K, Sedighi N, Moradi Z (2008) Inspiratory and expiratory high-resolution computed tomography (HRCT) in patients with chemical warfare agents exposure. Inhal Toxicol 20:507–511PubMedCrossRefGoogle Scholar
  11. Balali-Mood M, Hefazi M (2005) The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning. Fundam Clin Pharmacol 19:297–315PubMedCrossRefGoogle Scholar
  12. Balali-Mood M, Hefazi M (2006) Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol 99:273–282PubMedCrossRefGoogle Scholar
  13. Balali-Mood M, Afshari R, Zojaji R, Kahrom H, Kamrani M, Attaran D, Mousavi SR, Zare GA (2011) Delayed toxic effects of sulfur mustard on respiratory tract of Iranian veterans. Hum Exp Toxicol 30:1141–1149PubMedCrossRefGoogle Scholar
  14. Beheshti J, Mark EJ, Akbaei HM, Aslani J, Ghanei M (2006) Mustard lung secrets: long term clinicopathological study following mustard gas exposure. Pathol Res Pract 202:739–744PubMedCrossRefGoogle Scholar
  15. Berghoff RS (1919) The more common gases: their effect on the respiratory tract. Observation on two thousand cases. Arch Intern Med 24:678–684CrossRefGoogle Scholar
  16. Biljak VR, Rumora L, Cepelak I, Pancirov D, Popovic-Grle S, Soric J, Stjepanovic G, Grubisic TZ (2013) Gamma-glutamyltransferase and C-reactive protein in stable chronic obstructive pulmonary disease. Coll Antropol 37:221–227PubMedGoogle Scholar
  17. Biswas S, Hwang JW, Kirkham PA, Rahman I (2013) Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease. Curr Med Chem 20:1496–1530PubMedCrossRefGoogle Scholar
  18. Boskabady MH, Attaran D, Shaffei MN (2008) Airway responses to salbutamol after exposure to chemical warfare. Respirology 13:288–293PubMedCrossRefGoogle Scholar
  19. Boskabady MH, Amery S, Vahedi N, Khakzad MR (2011a) The effect of vitamin E on tracheal responsiveness and lung inflammation in sulfur mustard exposed guinea pigs. Inhal Toxicol 23:157–165PubMedCrossRefGoogle Scholar
  20. Boskabady MH, Vahedi N, Amery S, Khakzad MR (2011b) The effect of Nigella sativa alone, and in combination with dexamethasone, on tracheal muscle responsiveness and lung inflammation in sulfur mustard exposed guinea pigs. J Ethnopharmacol 137:1028–1034PubMedCrossRefGoogle Scholar
  21. Brimfield AA, Soni SD, Trimmer KA, Zottola MA, Sweeney RE, Graham JS (2012) Metabolic activation of sulfur mustard leads to oxygen free radical formation. Free Radic Biol Med 52:811–817PubMedCrossRefGoogle Scholar
  22. Celli BR, Locantore N, Yates J, Tal-Singer R, Miller BE, Bakke P, Calverley P, Coxson H, Crim C, Edwards LD, Lomas DA, Duvoix A, Macnee W, Rennard S, Silverman E, Vestbo J, Wouters E, Agusti A (2012) Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 185:1065–1072PubMedCrossRefGoogle Scholar
  23. Choi AMK, Levy BD (2011) Acute respiratory distress syndrome. In: Longo D (ed) Harrison’s principles of internal medicine. McGraw-Hill Companies Inc, New YorkGoogle Scholar
  24. Committee On The Survey Of The Health Effects Of Mustard Gas And Lewisite, Institute of Medicine (1992) Veterans at risk: health effects of mustard gas and lewisite. Pechura CM, Rall DP (eds). Washington, DC, National Academies PressGoogle Scholar
  25. Culic O, Erakovic V, Parnham MJ (2001) Anti-inflammatory effects of macrolide antibiotics. Eur J Pharmacol 429:209–229PubMedCrossRefGoogle Scholar
  26. Das SK, Mukherjee S, Smith MG, Chatterjee D (2003) Prophylactic protection by N-acetylcysteine against the pulmonary injury induced by 2-chloroethyl ethyl sulfide, a mustard analogue. J Biochem Mol Toxicol 17:177–184PubMedCrossRefGoogle Scholar
  27. De Nijs SB, Fens N, Lutter R, Dijkers E, Krouwels FH, Smids-Dierdorp BS, Van Steenwijk RP, Sterk PJ (2011) Airway inflammation and mannitol challenge test in COPD. Respir Res 12:1465–9921Google Scholar
  28. Dekhuijzen PN (2006) Acetylcysteine in the treatment of severe COPD. Ned Tijdschr Geneeskd 150:1222–1226PubMedGoogle Scholar
  29. Demedts IK, Demoor T, Bracke KR, Joos GF, Brusselle GG (2006) Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res 7:53PubMedPubMedCentralCrossRefGoogle Scholar
  30. Eftekharhosseini MA, et al. (1987) Analysing the Spirometric data of chemical injured patients and comparison with normal value. In: International congress of war gas in Iran, MashhadGoogle Scholar
  31. EftekharHosseini SA, Motamedi F, Semnanian S, MishMast NG (1988) Study of correlation between age, height, weight, cigarette smoking, duration of injury, type of chemical warfare and lung volumes and capacities. In: Abstracts of the First International Medical Congress on Chemical Warfare Agents in Iran. June 13-16, 1988. Mashhad University of Medical Sciences. Mashhad, Iran. No. 54.Google Scholar
  32. Elsayed NM, Omaye ST (2004) Biochemical changes in mouse lung after subcutaneous injection of the sulfur mustard 2-chloroethyl 4-chlorobutyl sulfide. Toxicology 199:195–206PubMedCrossRefGoogle Scholar
  33. Emad A, Emad Y (2007a) CD4/CD8 ratio and cytokine levels of the BAL fluid in patients with bronchiectasis caused by sulfur mustard gas inhalation. J Inflamm 4:2CrossRefGoogle Scholar
  34. Emad A, Emad Y (2007b) Comparison of bronchial responsiveness to ultrasonically nebulized distilled water (UNDW), methacholine, and ultrasonically nebulized distilled cold water (UDCW) in patients with sulfur mustard gas-induced asthma. Clin Toxicol (Phila) 45:565–570CrossRefGoogle Scholar
  35. Emad A, Emad Y (2007c) Increased in CD8 T lymphocytes in the BAL fluid of patients with sulfur mustard gas-induced pulmonary fibrosis. Respir Med 101:786–792PubMedCrossRefGoogle Scholar
  36. Emad A, Rezaian GR (1997) The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure: analysis of 197 cases. Chest 112:734–738PubMedCrossRefGoogle Scholar
  37. Emad A, Rezaian GR (1999) Immunoglobulins and cellular constituents of the BAL fluid of patients with sulfur mustard gas-induced pulmonary fibrosis. Chest 115:1346–1351PubMedCrossRefGoogle Scholar
  38. Emami MH, Talaei M, Panahi Y, Ghanei M (2014) Efficacy of omeprazole on cough, pulmonary function and quality of life of patients with sulfur mustard lung injury: a placebo-control, cross-over clinical trial study. J Res Med Sci 19:1027–1033PubMedPubMedCentralGoogle Scholar
  39. Everley PA, Dillman JF 3rd (2010) A large-scale quantitative proteomic approach to identifying sulfur mustard-induced protein phosphorylation cascades. Chem Res Toxicol 23:20–25PubMedCrossRefGoogle Scholar
  40. Fatal Exposure to Mustard Gas, W. http://www.vlib.us/medical/gaswar/mustrdpm.htm
  41. Fidan F, Unlu M, Koken T, Tetik L, Akgun S, Demirel R, Serteser M (2005) Oxidant-antioxidant status and pulmonary function in welding workers. J Occup Health 47:286–292PubMedCrossRefGoogle Scholar
  42. Foy JW, Schatz RA (2004) Inhibition of rat respiratory-tract cytochrome P-450 activity after acute low-level m-xylene inhalation: role in 1-nitronaphthalene toxicity. Inhal Toxicol 16:125–132PubMedCrossRefGoogle Scholar
  43. Gao X, Ray R, Xiao Y, Barker PE, Ray P (2007) Inhibition of sulfur mustard-induced cytotoxicity and inflammation by the macrolide antibiotic roxithromycin in human respiratory epithelial cells. BMC Cell Biol 8:17PubMedPubMedCentralCrossRefGoogle Scholar
  44. Gao X, Ray R, Xiao Y, Ray P (2008) Suppression of inducible nitric oxide synthase expression and nitric oxide production by macrolide antibiotics in sulfur mustard-exposed airway epithelial cells. Basic Clin Pharmacol Toxicol 103:255–261PubMedCrossRefGoogle Scholar
  45. Gao X, Ray R, Xiao Y, Ishida K, Ray P (2010) Macrolide antibiotics improve chemotactic and phagocytic capacity as well as reduce inflammation in sulfur mustard-exposed monocytes. Pulm Pharmacol Ther 23:97–106PubMedCrossRefGoogle Scholar
  46. Gao X, Anderson DR, Brown AW, Lin H, Amnuaysirikul J, Chua AL, Holmes WW, Ray P (2011) Pathological studies on the protective effect of a macrolide antibiotic, roxithromycin, against sulfur mustard inhalation toxicity in a rat model. Toxicol Pathol 39:1056–1064PubMedCrossRefGoogle Scholar
  47. Ghabili K, Agutter PS, Ghanei M, Ansarin K, Shoja MM (2010) Mustard gas toxicity: the acute and chronic pathological effects. J Appl Toxicol 30:627–643PubMedCrossRefGoogle Scholar
  48. Ghabili K, Agutter PS, Ghanei M, Ansarin K, Panahi Y, Shoja MM (2011) Sulfur mustard toxicity: history, chemistry, pharmacokinetics, and pharmacodynamics. Crit Rev Toxicol 41:384–403PubMedCrossRefGoogle Scholar
  49. Ghane Zadeh F, Mirzamani MS, Halabiyan R, Mahmoodzadeh Hosseini H, Imani Fooladi AA, Foroutan Koudehi M, Nourani MR (2014) The effects of sulfur mustard on expression of TGF-betas variants in lung epithelial cell line. J Recept Signal Transduct Res 4:1–5Google Scholar
  50. Ghanei M, et al. (1997) PFT changes in acute phase of Sulfur mustard exposure. Medical Doctor, Isfahan University of Medical SciencesGoogle Scholar
  51. Ghanei M, Harandi AA (2007) Long term consequences from exposure to sulfur mustard: a review. Inhal Toxicol 19:451–456PubMedCrossRefGoogle Scholar
  52. Ghanei M, Harandi AA (2010a) The respiratory toxicities of mustard gas. Iran J Med Sci (IJMS) 35:273–280Google Scholar
  53. Ghanei M, Harandi AA (2010b) Lung carcinogenicity of sulfur mustard. Clin Lung Cancer 11:13–17PubMedCrossRefGoogle Scholar
  54. Ghanei M, Harandi AA (2011) Molecular and cellular mechanism of lung injuries due to exposure to sulfur mustard: a review. Inhal Toxicol 23:363–371PubMedCrossRefGoogle Scholar
  55. Ghanei M, Fathi H, Mohammad MM, Aslani J, Nematizadeh F (2004a) Long-term respiratory disorders of claimers with subclinical exposure to chemical warfare agents. Inhal Toxicol 16:491–495PubMedCrossRefGoogle Scholar
  56. Ghanei M, Mokhtari M, Mohammad MM, Aslani J (2004b) Bronchiolitis obliterans following exposure to sulfur mustard: chest high resolution computed tomography. Eur J Radiol 52:164–169PubMedCrossRefGoogle Scholar
  57. Ghanei M, Hosseini AR, Arabbaferani Z, Shahkarami E (2005a) Evaluation of chronic cough in chemical chronic bronchitis patients. Environ Toxicol Pharmacol 20:6–10PubMedCrossRefGoogle Scholar
  58. Ghanei M, Khalili AR, Arab MJ, Mojtahedzadeh M, Aslani J, Lessan-Pezeshki M, Panahi Y, Alaeddini F (2005b) Diagnostic and therapeutic value of short-term corticosteroid therapy in exacerbation of mustard gas-induced chronic bronchitis. Basic Clin Pharmacol Toxicol 97:302–305PubMedCrossRefGoogle Scholar
  59. Ghanei M, Akbari Moqadam F, Mohammad MM, Aslani J (2006a) Tracheobronchomalacia and air trapping after mustard gas exposure. Am J Respir Crit Care Med 173:304–309PubMedCrossRefGoogle Scholar
  60. Ghanei M, Eshraghi M, Jalali AR, Aslani J (2006b) Evaluation of latent hemoptysis in Sulfur Mustard injured patients. Environ Toxicol Pharmacol 22:128–130PubMedCrossRefGoogle Scholar
  61. Ghanei M, Harandi AA, Rezaei F, Vasei A (2006c) Sinus CT scan findings in patients with chronic cough following sulfur mustard inhalation: a case–control study. Inhal Toxicol 18:1135–1138PubMedCrossRefGoogle Scholar
  62. Ghanei M, Panahi Y, Mojtahedzadeh M, Khalili AR, Aslani J (2006d) Effect of gamma interferon on lung function of mustard gas exposed patients, after 15 years. Pulm Pharmacol Ther 19:148–153PubMedCrossRefGoogle Scholar
  63. Ghanei M, Shohrati M, Harandi AA, Eshraghi M, Aslani J, Alaeddini F, Manzoori H (2007a) Inhaled corticosteroids and long-acting beta 2-agonists in treatment of patients with chronic bronchiolitis following exposure to sulfur mustard. Inhal Toxicol 19:889–894PubMedCrossRefGoogle Scholar
  64. Ghanei M, Alikhani SH, Mirmohammad SMM, Adibi I, Ramezani T, Aslani J (2007b) Occurrance of emphysema and accuracy of pulmonary function test (PFT), comparing with chest high resolution computed tomography (HRCT), in smokers with history of exposure to toxic fumes. J Mil Med 9:139–146Google Scholar
  65. Ghanei M, Adibi I, Farhat F, Aslani J (2008a) Late respiratory effects of sulfur mustard: how is the early symptoms severity involved? Chron Respir Dis 5:95–100PubMedCrossRefGoogle Scholar
  66. Ghanei M, Alikhani S, Adibi I, Mir Mohammad M, Ramazani T, Aslani J (2008b) Early onset emphysema in smokers with additional exposure to toxic fumes; occurrence and diagnosis. J Med Sci (Faisalabad) 8:222–227CrossRefGoogle Scholar
  67. Ghanei M, Tazelaar HD, Chilosi M, Harandi AA, Peyman M, Akbari HM, Shamsaei H, Bahadori M, Aslani J, Mohammadi A (2008c) An international collaborative pathologic study of surgical lung biopsies from mustard gas-exposed patients. Respir Med 102:825–830PubMedCrossRefGoogle Scholar
  68. Ghanei M, Ghayumi M, Ahakzani N, Rezvani O, Jafari M, Ani A, Aslani J (2010a) Noninvasive diagnosis of bronchiolitis obliterans due to sulfur mustard exposure: could high-resolution computed tomography give us a clue? Radiol Med 115:413–420PubMedCrossRefGoogle Scholar
  69. Ghanei M, Poursaleh Z, Harandi AA, Emadi SE, Emadi SN (2010b) Acute and chronic effects of sulfur mustard on the skin: a comprehensive review. Cutan Ocul Toxicol 29:269–277PubMedCrossRefGoogle Scholar
  70. Ghanei M, Chilosi M, Mohammad Hosseini Akbari H, Motiei-Langroudi R, Harandi AA, Shamsaei H, Bahadori M, Tazelaar HD (2011a) Use of immunohistochemistry techniques in patients exposed to sulphur mustard gas. Patholog Res Int 659603:6Google Scholar
  71. Ghanei M, Sheyacy M, Abbasi MA, Ani A, Aslani J (2011b) Correlation between the degree of air trapping in chest HRCT and cardiopulmonary exercise test parameters: could HRCT be a predictor of disease severity? Arch Iran Med 14:86–90PubMedGoogle Scholar
  72. Ghasemi Broumand M, Karamy GH, Pourfarzam SH, Emadi SN, Ghasemi H (2007) Late concurrent ophthalmic, respiratory, coetaneous and psychiatric complications of chemical weapons exposure in 479 war patients (Persian). Daneshvar Sci Res J Shahed Univ 70:81–92Google Scholar
  73. Ghasemi H, Owlia P, Jalali-Nadoushan MR, Pourfarzam S, Azimi G, Yarmohammadi ME, Shams J, Fallahi F, Moaiedmohseni S, Moin A, Yaraee R, Vaez-Mahdavi MR, Faghihzadeh S, Mohammad Hassan Z, Soroush MR, Naghizadeh MM, Ardestani SK, Ghazanfari T (2013) A clinicopathological approach to sulfur mustard-induced organ complications: a major review. Cutan Ocul Toxicol 32:304–324PubMedCrossRefGoogle Scholar
  74. Gilchrist HL, Matz PB (1933) The residual effects of wartime gases. US Government Printing Office, Washington, DCGoogle Scholar
  75. Guyton AC, Hall J (1996) Textbook of medical physiology. Saunders Company, PhiladelphiaGoogle Scholar
  76. Ham HY, Hong CW, Lee SN, Kwon MS, Kim YJ, Song DK (2012) Sulfur mustard primes human neutrophils for increased degranulation and stimulates cytokine release via TRPM2/p38 MAPK signaling. Toxicol Appl Pharmacol 258:82–88PubMedCrossRefGoogle Scholar
  77. Hankins JL, Klotz WC (1922) Permanent pulmonary effects of gas in warfare. Am Rev Tuberc 6:571–574Google Scholar
  78. Hefazi M, Attaran D, Mahmoudi M, Balali-Mood M (2005) Late respiratory complications of mustard gas poisoning in Iranian veterans. Inhal Toxicol 17:587–592PubMedCrossRefGoogle Scholar
  79. Heidarnejad H, Zendehdel N, Dastgiri S (1988) Temporal trend of clinical and spirometric parameters in mustard gas victims: a ten year study. Arch Iran Med 1:13–16Google Scholar
  80. Higashimoto Y, Iwata T, Okada M, Satoh H, Fukuda K, Tohda Y (2009) Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Respir Med 103:1231–1238PubMedCrossRefGoogle Scholar
  81. Hom J, Fernandes RM (2011) When should nebulized hypertonic saline solution be used in the treatment of bronchiolitis? Paediatr Child Health 16:157–158PubMedPubMedCentralCrossRefGoogle Scholar
  82. Hosseini K, Balali-Mood M (1998) Development of bronchiectasis, a late sequel of mustard gas exposure. Iran J Med Sci 23:81–84Google Scholar
  83. Hosseini-Khalili AR, Thompson J, Kehoe A, Hopkinson NS, Khoshbaten A, Soroush MR, Humphries SE, Montgomery H, Ghanei M (2008) Angiotensin-converting enzyme genotype and late respiratory complications of mustard gas exposure. BMC Pulm Med 8:15PubMedPubMedCentralCrossRefGoogle Scholar
  84. Hosseini-Khalili A, Haines DD, Modirian E, Soroush M, Khateri S, Joshi R, Zendehdel K, Ghanei M, Giardina C (2009) Mustard gas exposure and carcinogenesis of lung. Mut Res 678:1–6CrossRefGoogle Scholar
  85. Idani E, Ahmadzadeh A, Yadollahzadeh M, Heybar H, Valizadeh A, Moghimi J (2012) Clinical, high resolution computed tomography and pulmonary function in sulphur mustard victims. Acta Med Iran 50:603–608PubMedGoogle Scholar
  86. Institute of Medicine (US) Committee on the Survey of the Health Effects of Mustard Gas and Lewisite; Pechura CM, Rall DP (eds) (1933) Veterans at risk: the health effects of mustard gas and lewisite. National Academies Press, Washington, DC. B, excerpt from the residual effects of warfare gases (1933) available from: http://www.ncbi.nlm.nih.gov/books/nbk236056/
  87. Ji J, Von Scheele I, Bergstrom J, Billing B, Dahlen B, Lantz AS, Larsson K, Palmberg L (2014) Compartment differences of inflammatory activity in chronic obstructive pulmonary disease. Respir Res 15:104PubMedPubMedCentralCrossRefGoogle Scholar
  88. Jonigk D, Theophile K, Hussein K, Bock O, Lehmann U, Bockmeyer CL, Gottlieb J, Fischer S, Simon A, Welte T, Maegel L, Kreipe H, Laenger F (2010) Obliterative airway remodelling in transplanted and non-transplanted lungs. Virchows Arch 457:369–380PubMedCrossRefGoogle Scholar
  89. Jugg B, Fairhall S, Smith A, Rutter S, Mann T, Perrott R, Jenner J, Salguero J, Shute J, Sciuto AM (2013) N-acetyl-L-cysteine protects against inhaled sulfur mustard poisoning in the large swine. Clin Toxicol 51:216–224CrossRefGoogle Scholar
  90. Kadar T, Cohen M, Cohen L, Fishbine E, Sahar R, Brandeis R, Dachir S, Amir A (2013) Endothelial cell damage following sulfur mustard exposure in rabbits and its association with the delayed-onset ocular lesions. Cutan Ocul Toxicol 32:115–123PubMedCrossRefGoogle Scholar
  91. Karacsonyi C, Shanmugam N, Kagan E (2009) A clinically relevant in vitro model for evaluating the effects of aerosolized vesicants. Toxicol Lett 185:38–44PubMedCrossRefGoogle Scholar
  92. Karacsonyi C, Lee JH, Shanmugam N, Kagan E (2012) Epidermal growth factor receptor signaling mediates vesicant-induced airway epithelial secretion of interleukin-6 and production of mucin. Am J Respir Cell Mol Biol 46:157–164PubMedCrossRefGoogle Scholar
  93. Karami A, Ghanei M, Alaeddini F, Soltanpour MJ, Yassini M, Harandi AA (2011) Vascular endothelial growth factor in bronchoalveolar lavage fluid in sulfur mustard exposed lung patients. Oman Med J 26:118–121PubMedPubMedCentralCrossRefGoogle Scholar
  94. Karbasi A, Goosheh H, Aliannejad R, Saber H, Salehi M, Jafari M, Imani S, Saburi A, Ghanei M (2013) Pepsin and bile acid concentrations in sputum of mustard gas exposed patients. Saudi J Gastroenterol 19:121–125PubMedPubMedCentralCrossRefGoogle Scholar
  95. Karbasi-Afshar R, Panahi Y, Saburi A (2013a) Other considerations about carcinogenicity of sulfur mustard. Cancer Causes Control 24:2251–2252PubMedCrossRefGoogle Scholar
  96. Karbasi-Afshar R, Shahmari A, Madadi M, Poursaleh Z, Saburi A (2013b) Coronary angiography findings in lung injured patients with sulfur mustard compared to a control group. Ann Card Anaesth 16:188–192PubMedCrossRefGoogle Scholar
  97. Kehe K, Balszuweit F, Emmler J, Kreppel H, Jochum M, Thiermann H (2008) Sulfur mustard research--strategies for the development of improved medical therapy. Eplasty 8, e32PubMedPubMedCentralGoogle Scholar
  98. Keyser BM, Andres DK, Nealley E, Holmes WW, Benton B, Paradiso D, Appell A, Carpin C, Anderson DR, Smith WJ, Ray R (2013) Postexposure application of Fas receptor small-interfering RNA to suppress sulfur mustard-induced apoptosis in human airway epithelial cells: implication for a therapeutic approach. J Pharmacol Exp Ther 344:308–316PubMedCrossRefGoogle Scholar
  99. Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D (2003) Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 45:1136–1143PubMedCrossRefGoogle Scholar
  100. Korkmaz A, Kunak ZI, Paredes SD, Yaren H, Tan DX, Reiter RJ (2008) The use of melatonin to combat mustard toxicity. Review. Neuro Endocrinol Lett 29:614–619PubMedGoogle Scholar
  101. Larsson K (2008) Inflammatory markers in COPD. Clin Respir J 2(Suppl 1):84–87PubMedCrossRefGoogle Scholar
  102. Laskin JD, Black AT, Jan YH, Sinko PJ, Heindel ND, Sunil V, Heck DE, Laskin DL (2010) Oxidants and antioxidants in sulfur mustard-induced injury. Ann N Y Acad Sci 1203:92–100PubMedPubMedCentralCrossRefGoogle Scholar
  103. Lee HN, Surh YJ (2013) Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosis. Biochem Pharmacol 86:759–769PubMedCrossRefGoogle Scholar
  104. Leung AN, Fisher K, Valentine V, Girgis RE, Berry GJ, Robbins RC, Theodore J (1998) Bronchiolitis obliterans after lung transplantation: detection using expiratory HRCT. Chest 113:365–370PubMedCrossRefGoogle Scholar
  105. Malaviya R, Sunil VR, Cervelli J, Anderson DR, Holmes WW, Conti ML, Gordon RE, Laskin JD, Laskin DL (2010) Inflammatory effects of inhaled sulfur mustard in rat lung. Toxicol Appl Pharmacol 248:89–99PubMedPubMedCentralCrossRefGoogle Scholar
  106. Mansoor Ghanaei F, Alizadeh A (1999) Chest X-ray findings in Guilanian chemical warfare victims. J f Babol Univ Med Sci 1:8–13Google Scholar
  107. Mansour Razavi S, Salamati P, Saghafinia M, Abdollahi M (2012) A review on delayed toxic effects of sulfur mustard in Iranian veterans. Daru J Faculty Pharm Tehran Univ Med Sci 20:2008–2231Google Scholar
  108. Marrs TC, Al E (2007) Chemical warfare agents: toxicology and treatment. Wiley, ChichesterCrossRefGoogle Scholar
  109. Mcphillips K, Janssen WJ, Ghosh M, Byrne A, Gardai S, Remigio L, Bratton DL, Kang JL, Henson P (2007) TNF-alpha inhibits macrophage clearance of apoptotic cells via cytosolic phospholipase A2 and oxidant-dependent mechanisms. J Immunol 178:8117–8126PubMedCrossRefGoogle Scholar
  110. Mehrani H, Ghanei M, Aslani J, Golmanesh L (2009) Bronchoalveolar lavage fluid proteomic patterns of sulfur mustard-exposed patients. Proteomics Clin Appl 3:1191–1200PubMedCrossRefGoogle Scholar
  111. Mirsadraee M, Attaran D, Boskabady MH, Towhidi M (2005) Airway hyperresponsiveness to methacholine in chemical warfare victims. Respiration 72:523–528PubMedCrossRefGoogle Scholar
  112. Mirzamani MS, Nourani MR, Imani Fooladi AA, Zare S, Ebrahimi M, Yazdani S, Ghanei M, Karimfar MH (2013) Increased expression of transforming growth factor-beta and receptors in primary human airway fibroblasts from chemical inhalation patients. Iran J Allergy Asthma Immunol 12:144–152PubMedGoogle Scholar
  113. Mishra NC, Rir-Sima-AH J, Grotendorst GR, Langley RJ, Singh SP, Gundavarapu S, Weber WM, Pena-Philippides JC, Duncan MR, Sopori ML (2012) Inhalation of sulfur mustard causes long-term T cell-dependent inflammation: possible role of Th17 cells in chronic lung pathology. Int Immunopharmacol 13:101–108PubMedPubMedCentralCrossRefGoogle Scholar
  114. Moghaddam SJ, Barta P, Mirabolfathinejad SG, Ammar-Aouchiche Z, Garza NT, Vo TT, Newman RA, Aggarwal BB, Evans CM, Tuvim MJ, Lotan R, Dickey BF (2009) Curcumin inhibits COPD-like airway inflammation and lung cancer progression in mice. Carcinogenesis 30:1949–1956PubMedPubMedCentralCrossRefGoogle Scholar
  115. Mostafa Ghanei AA-H, Amin A (2011) Diagnosis and treatment of respiratory diseases in chemical injuries. Resaneh Takhassosi, TehranGoogle Scholar
  116. Mostafa G, Mehdi E, Mohammadreza P, Farshid A, Ahmad RJ, Sajad V (2007) Pulmonary function test trend in adult bronchiolitis obliterans. Tanaffos J 6:40–46Google Scholar
  117. Mukhopadhyay S, Mukherjee S, RAY BK, Ray A, Stone WL, Das SK (2010) Antioxidant liposomes protect against CEES-induced lung injury by decreasing SAF-1/MAZ-mediated inflammation in the guinea pig lung. J Biochem Mol Toxicol 24:187–194PubMedCrossRefGoogle Scholar
  118. Muskat PC (2008) Mass casualty chemical exposure and implications for respiratory failure. Respir Care 53:58–66PubMedGoogle Scholar
  119. Myong NH, Shin DH, Lee KY (2001) A clinicopathologic study on three cases of constrictive bronchiolitis. J Kor Med Sci 16:150–154CrossRefGoogle Scholar
  120. Panahi Y, Ghanei M, Aslani J, Mojtahedzadeh M (2005) The therapeutic effect of gamma interferon in chronic bronchiolitis due to mustard gas. Iran J Allergy Asthma Immunol 4:83–90PubMedGoogle Scholar
  121. Panahi Y, Ghanei M, Bashiri S, Hajihashemi A, Sahebkar A (2015) Short-term Curcuminoid Supplementation for Chronic Pulmonary Complications due to Sulfur Mustard Intoxication: Positive Results of a Randomized Double-blind Placebo-controlled Trial. Drug Res (Stuttg) 65(11):567–73. doi: 10.1055/s-0034-1389986. PMID: 25268878Google Scholar
  122. Panahi Y, Ghanei M, Hajhashemi A, Sahebkar A (2014b) Effects of curcuminoids-piperine combination on systemic oxidative stress, clinical symptoms and quality of life in subjects with chronic pulmonary complications due to sulfur mustard: a randomized controlled trial. J Diet Suppl 29:29Google Scholar
  123. Pirzad G, Jafari M, Tavana S, Sadrayee H, Ghavami S, Shajiei A, Ghanei M (2010) The role of Fas-FasL signaling pathway in induction of apoptosis in patients with sulfur mustard-induced chronic bronchiolitis. J Toxicol 2010:373612PubMedCrossRefGoogle Scholar
  124. Pohanka M, Sobotka J, Jilkova M, Stetina R (2011) Oxidative stress after sulfur mustard intoxication and its reduction by melatonin: efficacy of antioxidant therapy during serious intoxication. Drug Chem Toxicol 34:85–91PubMedCrossRefGoogle Scholar
  125. Pohanka M, Stetina R, Svobodova H, Ruttkay-Nedecky B, Jilkova M, Sochor J, Sobotka J, Adam V, Kizek R (2013) Sulfur mustard causes oxidative stress and depletion of antioxidants in muscles, livers, and kidneys of Wistar rats. Drug Chem Toxicol 36:270–276PubMedCrossRefGoogle Scholar
  126. Pohl C, Papritz M, Moisch M, Wubbeke C, Hermanns MI, Uboldi C, Dei-Anang J, Mayer E, Kirkpatrick CJ, Kehe K (2009) Acute morphological and toxicological effects in a human bronchial coculture model after sulfur mustard exposure. Toxicol Sci 112:482–489PubMedCrossRefGoogle Scholar
  127. Pourfarzam S, Ghazanfari T, Yaraee R, Ghasemi H, Hassan ZM, Faghihzadeh S, Ardestani SK, Kariminia A, Fallahi F, Soroush MR, Merasizadeh J, Mahlojirad M, Naghizadeh MM, Ghanei M (2009) Serum levels of IL-8 and IL-6 in the long term pulmonary complications induced by sulfur mustard: Sardasht-Iran Cohort Study. Int Immunopharmacol 9:1482–1488PubMedCrossRefGoogle Scholar
  128. Poursaleh Z, Harandi AA, Vahedi E, Ghanei M (2012) Treatment for sulfur mustard lung injuries; new therapeutic approaches from acute to chronic phase. Daru J Faculty Pharm Tehran Univ Med Sci 20:27CrossRefGoogle Scholar
  129. Ray R, Keyser B, Benton B, Daher A, Simbulan-Rosenthal CM, Rosenthal DS (2008) Sulfur mustard induces apoptosis in cultured normal human airway epithelial cells: evidence of a dominant caspase-8-mediated pathway and differential cellular responses. Drug Chem Toxicol 31:137–148PubMedCrossRefGoogle Scholar
  130. Razavi SM, Ghanei M, Salamati P, Safiabadi M (2013a) Long-term effects of mustard gas on respiratory system of Iranian veterans after Iraq-Iran war: a review. Chin J Traumatol 16:163–168PubMedGoogle Scholar
  131. Razavi SM, Karbakhsh M, Salamati P (2013b) Preventive measures against the mustard gas: a review. Med J Islam Repub Iran 27:83–90PubMedPubMedCentralGoogle Scholar
  132. Report of the mission dispatched by the Secretary-General to investigate allegations of the use of chemical weapons in the conflict between the Islamic Republic of Iran and Iraq, R NGoogle Scholar
  133. Rosenthal DS, Velena A, Chou FP, Schlegel R, RAY R, Benton B, Anderson D, Smith WJ, Simbulan-Rosenthal CM (2003) Expression of dominant-negative Fas-associated death domain blocks human keratinocyte apoptosis and vesication induced by sulfur mustard. J Biol Chem 278:8531–8540PubMedCrossRefGoogle Scholar
  134. Roushan N, Zali F, Abtahi H, Asadi M, Taslimi R, Aletaha N (2014) Reflux esophagitis in war-related sulfur mustard lung disease. Med J Islam Repub Iran. 2014;28:30. eCollection 2014Google Scholar
  135. Saber H, Saburi A, Ghanei M (2012) Clinical and paraclinical guidelines for management of sulfur mustard induced bronchiolitis obliterans; from bench to bedside. Inhal Toxicol 24:900–906PubMedCrossRefGoogle Scholar
  136. Saburi A, Ghanei M (2013) Comments on “sulfur mustard and respiratory diseases,” Tang & Loke (2012) and a prepared integrated mechanism for chronic pulmonary disease from exposure to sulfur mustard. Crit Rev Toxicol 43:275–276PubMedCrossRefGoogle Scholar
  137. Saburi A, Shohrati M, Ghanei M (2012a) Perspective in future pharmacological approach to sulfur mustard lung injuries. J Res Med Sci 17:1092–1093PubMedPubMedCentralGoogle Scholar
  138. Saburi A, Shohrati M, Karbasi-Afshar R (2012b) Immune-based pathogenesis of sulfur mustard; much still need to be done! Iran J Allergy Asthma Immunol 11(4):349–350. doi:011.04/ijaai.349350Google Scholar
  139. Sagar S, Kumar P, Behera RR, Pal A (2014) Effects of CEES and LPS synergistically stimulate oxidative stress inactivates OGG1 signaling in macrophage cells. J Hazard Mater 278:236–249PubMedCrossRefGoogle Scholar
  140. Sandall TE (1922) The later effects of gas poisoning. Lancet 203:857–859CrossRefGoogle Scholar
  141. Sarsour EH, Kumar MG, Chaudhuri L, Kalen AL, Goswami PC (2009) Redox control of the cell cycle in health and disease. Antioxid Redox Signal 11:2985–3011PubMedPubMedCentralCrossRefGoogle Scholar
  142. Sawyer TW (1999) Synergistic protective effects of selected arginine analogues against sulphur mustard toxicity in neuron culture. Toxicol Appl Pharmacol 155:169–176PubMedCrossRefGoogle Scholar
  143. Sayer NM, Whiting R, Green AC, Anderson K, Jenner J, Lindsay CD (2010) Direct binding of sulfur mustard and chloroethyl ethyl sulphide to human cell membrane-associated proteins; implications for sulfur mustard pathology. J Chromatogr B Analyt Technol Biomed Life Sci 878:1426–1432PubMedCrossRefGoogle Scholar
  144. Shabestari MM, Jabbari F, Gohari B, Moazen N, Azizi H, Moghiman T, Ibrahimzadeh S, Amirabadi A (2011) Coronary artery angiographic changes in veterans poisoned by mustard gas. Cardiology 119:208–213PubMedCrossRefGoogle Scholar
  145. Shohrati M, Ghanei M, Shamspour N, Babaei F, Abadi MN, Jafari M, Harandi AA (2010a) Glutathione and malondialdehyde levels in late pulmonary complications of sulfur mustard intoxication. Lung 188:77–83PubMedCrossRefGoogle Scholar
  146. Shohrati M, Shamspour N, Babaei F, Harandi AA, Mohsenifar A, Aslani J, Ghanei M (2010b) Evaluation of activity and phenotype of alpha1-antitrypsin in a civil population with respiratory complications following exposure to sulfur mustard 20 years ago. Biomarkers 15:47–51PubMedCrossRefGoogle Scholar
  147. Shohrati M, Ghanei M, Harandi AA, Foroghi S (2012) Effect of nebulized morphine on dyspnea of mustard gas-exposed patients: a double-blind randomized clinical trial study. Pulm Med 610921:19Google Scholar
  148. Shohrati M, Amini-Harandi A, Najafian B, Saburi A, Ghanei M (2014a) The role of serum level of interleukin-6 in severity of pulmonary complications of sulfur mustard injuries. Iran J Med Sci 39:382–386PubMedPubMedCentralGoogle Scholar
  149. Shohrati M, Karimzadeh I, Saburi A, Khalili H, Ghanei M (2014b) The role of N-acetylcysteine in the management of acute and chronic pulmonary complications of sulfur mustard: a literature review. Inhal Toxicol 26:507–523PubMedCrossRefGoogle Scholar
  150. Simpson JL, Gibson PG, Yang IA, Upham J, James A, Reynolds PN, Hodge S (2013) Impaired macrophage phagocytosis in non-eosinophilic asthma. Clin Exp Allergy 43:29–35PubMedCrossRefGoogle Scholar
  151. Sohrabpour H (1987) Observation and clinical manifestations of patients injured with mustard gas. Med J Islam Repub Iran 1:32–37Google Scholar
  152. Sohrabpour H, Masjedi M, Bahadori M (1988) Late complications of sulfur mustard in respiratory system. Med J Islam Rep Iran 2:171–174Google Scholar
  153. Soltan-Sharifi MS, Mojtahedzadeh M, Najafi A, Reza Khajavi M, Reza Rouini M, Moradi M, Mohammadirad A, Abdollahi M (2007) Improvement by N-acetylcysteine of acute respiratory distress syndrome through increasing intracellular glutathione, and extracellular thiol molecules and anti-oxidant power: evidence for underlying toxicological mechanisms. Hum Exp Toxicol 26:697–703PubMedCrossRefGoogle Scholar
  154. Steinritz D, Weber J, Balszuweit F, Thiermann H, Schmidt A (2013) Sulfur mustard induced nuclear translocation of glyceraldehyde-3-phosphate-dehydrogenase (GAPDH). Chem Biol Interact 206:529–535. http://chemm.nlm.nih.gov/mustard_hospital_mmg.htm and http://www.cdc.gov/niosh/ershdb/EmergencyResponseCard_29750008.html
  155. Steinritz D, Schmidt A, Simons T, Ibrahim M, Morguet C, Balszuweit F, Thiermann H, Kehe K, Bloch W, Bolck B (2014) Chlorambucil (nitrogen mustard) induced impairment of early vascular endothelial cell migration - Effects of alpha-linolenic acid and N-acetylcysteine. Chem Biol Interact 2:143–150CrossRefGoogle Scholar
  156. Taghaddosinejad F, Fayyaz AF, Behnoush B (2011) Pulmonary complications of mustard gas exposure: a study on cadavers. Acta Med Iran 49:233–236PubMedGoogle Scholar
  157. Tang FR, Loke WK (2012) Sulfur mustard and respiratory diseases. Crit Rev Toxicol 42:688–702PubMedCrossRefGoogle Scholar
  158. Taravati A, Ardestani SK, Ziaee AA, Ghorbani A, Soroush MR, Faghihzadeh S, Kazemi H, Rezaei A, Hoseini H, Ghazanfari T (2013) Effects of paraoxonase 1 activity and gene polymorphisms on long-term pulmonary complications of sulfur mustard-exposed veterans. Int Immunopharmacol 17:974–979PubMedCrossRefGoogle Scholar
  159. Tewari-Singh N, Inturi S, Jain AK, Agarwal C, Orlicky DJ, White CW, Agarwal R, Day BJ (2014) Catalytic antioxidant AEOL 10150 treatment ameliorates sulfur mustard analog 2-chloroethyl ethyl sulfide-associated cutaneous toxic effects. Free Radic Biol Med 72:285–295PubMedPubMedCentralCrossRefGoogle Scholar
  160. Tse HN, Tseng CZ (2014) Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease. Int J Chronic Obstr Pulm Dis 9:825–836CrossRefGoogle Scholar
  161. Vahedi E, Taheri S, Alaedini F, Poursaleh Z, Ameli J, Ghanei M (2012) Correlations of sleep disorders with severity of obstructive airway disease in mustard gas-injured patients. Sleep Breath 16:443–451PubMedCrossRefGoogle Scholar
  162. Van Helden HP, Kuijpers WC, Diemel RV (2004) Asthmalike symptoms following intratracheal exposure of Guinea pigs to sulfur mustard aerosol: therapeutic efficacy of exogenous lung surfactant curosurf and salbutamol. Inhal Toxicol 16:537–548PubMedCrossRefGoogle Scholar
  163. Veress LA, O’neill HC, Hendry-Hofer TB, Loader JE, Rancourt RC, White CW (2010) Airway obstruction due to bronchial vascular injury after sulfur mustard analog inhalation. Am J Respir Crit Care Med 182:1352–1361PubMedPubMedCentralCrossRefGoogle Scholar
  164. Veress LA, Hendry-Hofer TB, Loader JE, Rioux JS, Garlick RB, White CW (2013) Tissue plasminogen activator prevents mortality from sulfur mustard analog-induced airway obstruction. Am J Respir Cell Mol Biology 48:439–447CrossRefGoogle Scholar
  165. Veress LA, Anderson DR, Hendry-Hofer TB, Houin PR, Rioux JS, Garlick RB, Loader JE, Paradiso DC, Smith RW, Rancourt RC, Holmes WW, White CW (2015) Airway tissue plasminogen activator prevents acute mortality due to lethal sulfur mustard inhalation. Toxicol Sci Off J Soc Toxicol 143:178–184CrossRefGoogle Scholar
  166. Vijayaraghavan R (1997) Modifications of breathing pattern induced by inhaled sulphur mustard in mice. Arch Toxicol 71:157–164PubMedCrossRefGoogle Scholar
  167. Weinberger B, Laskin JD, Sunil VR, Sinko PJ, Heck DE, Laskin DL (2011) Sulfur mustard-induced pulmonary injury: therapeutic approaches to mitigating toxicity. Pulm Pharmacol Ther 24:92–99PubMedCrossRefGoogle Scholar
  168. Wigenstam E, Rocksen D, Ekstrand-Hammarstrom B, Bucht A (2009) Treatment with dexamethasone or liposome-encapsuled vitamin E provides beneficial effects after chemical-induced lung injury. Inhal Toxicol 21:958–964PubMedCrossRefGoogle Scholar
  169. Willems J (1989) Clinical management of mustard gas casualties. Ann Med Mil Belg 3:1–61Google Scholar
  170. Zafarghandi MR, Soroush MR, Mahmoodi M, Naieni KH, Ardalan A, Dolatyari A, Falahati F, Mirmohammadkhani M, Mousavi B, Ghanei M (2013) Incidence of cancer in Iranian sulfur mustard exposed veterans: a long-term follow-up cohort study. Cancer Causes Control 24:99–105PubMedCrossRefGoogle Scholar
  171. Zarin AA, Behmanesh M, Tavallaei M, Shohrati M, Ghanei M (2010) Overexpression of transforming growth factor (TGF)-beta1 and TGF-beta3 genes in lung of toxic-inhaled patients. Exp Lung Res 36:284–291PubMedCrossRefGoogle Scholar
  172. Zhang Z, Riviere JE, Monteiro-Riviere NA (1995) Evaluation of protective effects of sodium thiosulfate, cysteine, niacinamide and indomethacin on sulfur mustard-treated isolated perfused porcine skin. Chem Biol Interact 96:249–262PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.Chemical Injuries Research Center and Faculty of MedicineBaqiyatallah University of Medical SciencesTehranIran

Personalised recommendations